Company Filing History:
Years Active: 2009
Title: Alexander Fiedler: Innovator in Oligonucleotide Therapeutics
Introduction
Alexander Fiedler is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents targeting pancreatic tumors. His innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Fiedler holds a patent for "Oligonucleotides, agents containing these oligonucleotides, and the use thereof." This invention relates to specific oligonucleotides and pharmaceutical agents that incorporate these oligonucleotides. The therapeutic use of these oligonucleotides is particularly aimed at inhibiting the proliferation of pancreatic tumors. This innovation represents a promising avenue for antisense therapy in treating pancreatic cancer. He has 1 patent to his name.
Career Highlights
Fiedler is associated with Universitätsklinikum Schleswig-Holstein, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from pancreatic tumors.
Collaborations
Fiedler collaborates with esteemed colleagues, including Ernst Bayer and Inge Bayer, who serves as the Legal Representative. Their combined expertise enhances the potential impact of Fiedler's innovations in the medical field.
Conclusion
Alexander Fiedler's contributions to the development of oligonucleotide-based therapies highlight his role as an innovator in the fight against pancreatic cancer. His work exemplifies the intersection of science and medicine, paving the way for future advancements in cancer treatment.